Therapeutic Vaccination Using Cationic Liposome-Adjuvanted HIV Type 1 Peptides Representing HLA-Supertype-Restricted Subdominant T Cell Epitopes: Safety, Immunogenicity, and Feasibility in Guinea-Bissau-Reference-Cited by-同舟云学术

Therapeutic Vaccination Using Cationic Liposome-Adjuvanted HIV Type 1 Peptides Representing HLA-Supertype-Restricted Subdominant T Cell Epitopes: Safety, Immunogenicity, and Feasibility in Guinea-Bissau

Published:2013-11 Issue:11 Volume:29 Page:1504-1512
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Román Victor Raúl Gómez¹,Jensen Kristoffer Jarlov¹,Jensen Sanne Skov¹,Leo-Hansen Christian¹,Jespersen Sanne²,Té David da Silva³,Rodrigues Candida Medina³,Janitzek Christoph Mikkel¹,Vinner Lasse¹,Katzenstein Terese Lea⁴,Andersen Peter⁵,Kromann Ingrid⁵,Andreasen Lars Vibe⁵,Karlsson Ingrid¹,Fomsgaard Anders¹⁶

Affiliation:

1. Department of Virology, Statens Serum Institut, Copenhagen, Denmark.

2. The Bandim Health Project, Bissau, Guinea-Bissau.

3. Centro de Tratamento Ambulatório (CTA), Hospital Nacional Simão Mendes (HNSM), Bissau, Guinea-Bissau.

4. Department of Infectious Diseases, University Hospital Copenhagen, Copenhagen, Denmark.

5. Vaccine Research and Development, Statens Serum Institut, Copenhagen, Denmark.

6. Infectious Disease Research Unit, Clinical Institute, University of Southern Denmark, Odense, Denmark.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2013.0076

Reference51 articles.

1. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing?

2. Two Distinct Epidemics: The Rise of HIV-1 and Decline of HIV-2 Infection Between 1990 and 2007 in Rural Guinea-Bissau

3. Therapeutic Vaccines for Chronic Infections

4. Prospects for the control of AIDS by immunizing seropositive individuals

5. Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogens

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of different immunomodulating liposome-based adjuvants and injection sites on immunogenicity in pigs;Microbes and Infection;2024-07

2. A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4 ⁺ T-cell-dependent strain-transcending protective immunity in rodent models;mBio;2023-12-19

3. Reconstituted dry powder formulations of ZnO-adjuvanted ovalbumin induce equivalent antigen specific antibodies but lower T cell responses than ovalbumin adjuvanted with Alhydrogel® or cationic adjuvant formulation 01 (CAF®01);International Journal of Pharmaceutics;2023-12

4. Cohort Profile Update: The Bissau HIV Cohort—a cohort of HIV-1, HIV-2 and co-infected patients;International Journal of Epidemiology;2023-05-17

5. Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials;The Brazilian Journal of Infectious Diseases;2023-05